Carrie L. Lucas, Ph.D.
Affiliations: | 2010 | Harvard University, Cambridge, MA, United States |
Area:
Immunology, Cell BiologyGoogle:
"Carrie Lucas"Parents
Sign in to add mentor| Megan Sykes | grad student | 2010 | Harvard | |
| (Mechanisms of Deletional Tolerance of Peripheral CD8+ T Cells Induced by Anti-CD40L and Allogeneic Bone Marrow Transplantation.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lanahan SM, Yang L, Jones KM, et al. (2024) PI3Kγ in B cells promotes antibody responses and generation of antibody-secreting cells. Nature Immunology |
| Axisa PP, Yoshida TM, Lucca LE, et al. (2022) A multiple sclerosis-protective coding variant reveals an essential role for HDAC7 in regulatory T cells. Science Translational Medicine. 14: eabl3651 |
| Reed JC, Preston-Hurlburt P, Philbrick W, et al. (2020) The receptor for advanced glycation endproducts (RAGE) modulates T cell signaling. Plos One. 15: e0236921 |
| Takeda AJ, Maher TJ, Zhang Y, et al. (2019) Human PI3Kγ deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology. Nature Communications. 10: 4364 |
| Carpier JM, Lucas CL. (2017) Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency. Frontiers in Immunology. 8: 2005 |
| Rao VK, Webster S, Dalm VASH, et al. (2017) Effective 'Activated PI3Kδ Syndrome'-targeted therapy with the PI3Kδ inhibitor leniolisib. Blood |
| Lucas CL, Chandra A, Nejentsev S, et al. (2016) PI3Kδ and primary immunodeficiencies. Nature Reviews. Immunology |
| Elkaim E, Neven B, Bruneau J, et al. (2016) Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study. The Journal of Allergy and Clinical Immunology |
| Lucas CL, Zhang Y, Venida A, et al. (2014) Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K. The Journal of Experimental Medicine. 211: 2537-47 |
| Haspot F, Li HW, Lucas CL, et al. (2014) Allospecific rejection of MHC class I-deficient bone marrow by CD8 T cells. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 14: 49-58 |